ECMO Braile Biomédica® in COVID-19 Patients Post-market Clinical Trial to Verify the Performance of the ECMO System
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
Retrospective data collection to evaluate the gas transfer capacity of the Braile Biomédica® OxyPrime® ECMO BRCoating® Membrane Oxygenator in COVID-19 patients during the pandemic.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Patients ≥ 18 years old, with a previous diagnosis of COVID-19, who were placed on ECMO using the Oxyprime® ECMO Braile Biomédica® Membrane Oxygenator, from March 2020 to July 2022, following the Instructions for Use (IFU) of the products.
Locations
Other Locations
Brazil
Hospital Brasília
RECRUITING
Lago Sul
Contact Information
Primary
Glacia G Basso
glaucia.basso@braile.com.br
+55(17)2136-7005
Backup
Priscila C Joao
priscila.joao@braile.com.br
+55(17)2136-7005
Time Frame
Start Date: 2023-09-14
Estimated Completion Date: 2024-03
Participants
Target number of participants: 30
Related Therapeutic Areas
Sponsors
Leads: Braile Biomedica Ind. Com. e Repr. Ltda.